693 related articles for article (PubMed ID: 11694206)
1. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
2. Precessation treatment with nicotine skin patch facilitates smoking cessation.
Rose JE; Behm FM; Westman EC; Kukovich P
Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
[TBL] [Abstract][Full Text] [Related]
3. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Rose JE; Herskovic JE; Behm FM; Westman EC
Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
[TBL] [Abstract][Full Text] [Related]
4. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
[TBL] [Abstract][Full Text] [Related]
5. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.
Rose JE; Behm FM
Nicotine Tob Res; 2004 Jun; 6(3):523-32. PubMed ID: 15203786
[TBL] [Abstract][Full Text] [Related]
6. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
7. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
8. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements.
Snell LD; Glanz J; Tabakoff B;
Alcohol Clin Exp Res; 2002 Jul; 26(7):1105-13. PubMed ID: 12170121
[TBL] [Abstract][Full Text] [Related]
9. Nicotine patch therapy in adolescent smokers.
Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
[TBL] [Abstract][Full Text] [Related]
10. Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence.
Gilbert DG; Zuo Y; Browning RA; Shaw TM; Rabinovich NE; Gilbert-Johnson AM; Plath L
Nicotine Tob Res; 2003 Dec; 5(6):813-9. PubMed ID: 14668065
[TBL] [Abstract][Full Text] [Related]
11. Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking.
Prokhorov AV; Hudmon KS; de Moor CA; Kelder SH; Conroy JL; Ordway N
Nicotine Tob Res; 2001 May; 3(2):151-5. PubMed ID: 11403729
[TBL] [Abstract][Full Text] [Related]
12. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
[TBL] [Abstract][Full Text] [Related]
14. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
16. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase B in the brains of smokers.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G
Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412
[TBL] [Abstract][Full Text] [Related]
20. Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects.
Berggren U; Eriksson M; Fahlke C; Blennow K; Balldin J
Alcohol Alcohol; 2007; 42(3):267-71. PubMed ID: 17526638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
